elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q41861093-8052D7DF-A6CF-4CC5-9BA1-FC1A7A3F5CC7
Q41861093-8052D7DF-A6CF-4CC5-9BA1-FC1A7A3F5CC7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41861093-8052D7DF-A6CF-4CC5-9BA1-FC1A7A3F5CC7
Managing the dose escalation of biologics in an era of cost containment: the need for a rational strategy.
P2860
Q41861093-8052D7DF-A6CF-4CC5-9BA1-FC1A7A3F5CC7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41861093-8052D7DF-A6CF-4CC5-9BA1-FC1A7A3F5CC7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f9a28a415931c675ee5d5509d749a787b4e7de87
P2860
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.